Virginia Patent of the Month – August 2023
Medical advancements continue to reshape the landscape of cancer diagnosis and treatment. One such innovation is the hand-held radioprobe designed to measure radiation emitted from implanted radiation sources. This groundbreaking invention holds the potential to revolutionize cancer therapy and management, providing physicians with a precise tool for assessing radiation levels and facilitating more targeted treatments.
Developed by Best Medical International, Inc., this hand-held radioprobe offers a multifaceted solution to the challenges of cancer treatment. The probe comprises a handle and an elongated shaft, designed to be inserted into a body cavity or held over tissue of interest. Equipped with radiation sensors, the shaft detects and measures radiation emitted from radiation-emitting sources implanted within the body or tissues. This allows for accurate monitoring of radioisotopes and radioactive seeds used in cancer therapies, ensuring optimal dosages and targeted radiation delivery.
What sets this radioprobe apart is its detachable probe portion, which can be rotated into multiple positions for precise radiation detection. Additionally, a sterile probe cover safeguards against contamination and enhances clinical safety. A signal processing device processes the radiation data collected by the probe, providing valuable insights to healthcare professionals.
Communication capabilities make this radioprobe even more powerful. Equipped with a communication medium, the probe can transmit processed radiation data to an external data processor unit. This data can then be further analyzed and displayed on devices such as computers, laptops, tablets, or cell phones. Physicians gain a comprehensive view of radiation levels, enabling them to make informed decisions about treatment courses.
With potential applications ranging from brachytherapy to cancer imaging and beyond, the hand-held radioprobe represents a game-changing advancement in the field of cancer care. By facilitating precise radiation measurement and enabling real-time data analysis, this invention by Best Medical International paves the way for more effective and personalized cancer therapies, ultimately improving patient outcomes and quality of life. As medical technology continues to evolve, the hand-held radioprobe stands as a testament to human ingenuity in the pursuit of better healthcare solutions.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
